Treating bacterial infections without antibiotics
With the Bionic 880, borreliosis and its co-infections can be treated gently, without antibiotics, using pulsed light
Overview of treatment options for photon or light therapy
- Local treatment of pain, wounds, infections, burns
- Hormone harmonization, wide-ranging indications—hormones involved in most illnesses, 5 points are treated
- Treatment of bacterial infections without antibiotics, including the necessary detoxification
- Treatment of viral illnessesTreating borreliosis and other bacterial diseases with photon therapy
Practice-tested therapy concepts and complemental medical products for natural treatment
Natural therapists who would like to use the Bionic 880 are trained in its use by experienced employees of Buschkühl GmbH. A treating therapist always supervises the use of photon therapy. For protracted treatment, the easy-to-use device can also be prescribed for a patient, so that after comprehensive instruction the treatment can be performed at home.
Application reports by experienced therapists and the indication list for the Bionic 880 are available to interested members of the medical community following registration at http://www.biophoton.de/registrieren.html.
The transducer supplements the Bionic 880 to provide information to patients. Like the Bionic 880, it is ready for use immediately.
H. Buschkühl GmbH
Since 1996, the H. Buschkühl GmbH company has specialized in the sale of innovative medical and wellness devices and products. The Bionic 880, which is considered to be the original in photon therapy, is produced by the H. Buschkühl GmbH company in Germany and is used by doctors and alternative practitioners around the world. In 2013, it was awarded the "Best of 2013" industry award for the second time.
More information at www.biophoton.de
Diese Pressemitteilungen könnten Sie auch interessieren
Weitere Informationen zum Thema "Medizintechnik":
Smart Cities knacken 2025 weltweit die 2-Billionen-Dollar-Marke
Das Marktforschungsunternehmen Frost & Sullivan prognostiziert für die Smart City goldene Zeiten. Im Jahr 2025 soll sie Geschäftsmöglichkeiten im Wert von zwei Billionen US-Dollar generieren. In der Hauptrolle der Smart Cities: Künstliche Intelligenz.Weiterlesen